Salestools LogoSalestools
Salestools AI-agenter
Løsninger
Ressourcer
Virksomhed
Priser
Salestools Logo

Salestools

#1 AI-agent til salgsteams og Go-to-Market-teams. Sælg mere, hurtigere, med mindre indsats.

Produkt

  • AI-salgsagenter
  • Intent-data
  • Teknologidata
  • Besøgssporing
  • Co-Pilot
  • Socialt salg

Løsninger

  • Kundeservice
  • E-handel
  • SaaS
  • Enterprise
  • Lille virksomhed

Ressourcer

  • Rapporten
  • Dokumentation
  • API-reference
  • Hjælpecenter
  • Blog
  • Case-studier
  • Webinarer

Virksomhed

  • Om os
  • Karriere
  • Presse
  • Kontakt
  • Partnere

Vores lokationer

  • New York, HQ
  • Bukarest, AI-forskningslaboratorium
  • Zug, Schweiz

© 2026 Salestools. Alle rettigheder forbeholdes.

Datavilkår & sikkerhedPrivatlivspolitikServicevilkårAcceptable Use
Alle systemer operationelle
Salestools LogoSalestools
Salestools AI-agenter
Løsninger
Ressourcer
Virksomhed
Priser
Back to Reports
Fundraising

Poolside

Poolside Raises $1B in Strategic

Paris, FranceOctober 30, 20252 min read
Employees
150+

Poolside Raises $1B in Strategic


Poolside has successfully raised $1B in a Strategic at a $12B valuation led by Nvidia, Felicis Ventures, Redpoint.


Company Overview


Poolside is a AI/ML company headquartered in Paris, France, founded in 2023 with 150+ employees.


AI coding assistant platform that generates, explains, and optimizes code for developers using generative AI


Fundraising Details


  • Amount Raised: $1B
  • Round Type: Strategic
  • Valuation: $12B
  • Date: 2025-10-30
  • Investors: Nvidia, Felicis Ventures, Redpoint

About Poolside


AI coding assistant platform that generates, explains, and optimizes code for developers using generative AI The company is positioned in the AI/ML sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: Paris, France
  • Founded: 2023
  • Team Size: 150+
  • Industry: AI/ML

What This Means


This funding round demonstrates strong investor confidence in Poolside's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The AI/ML sector continues to attract significant investment as companies innovate to meet evolving market demands. Poolside's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $12B valuation marks an important milestone for Poolside, positioning the company among notable players in the AI/ML industry.


Looking Ahead


With this new capital, Poolside is well-positioned to execute on its growth strategy and continue building innovative solutions in the AI/ML space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2025-10-30. For more information about Poolside, visit their headquarters at Paris, France.

Company Info

Headquarters
Paris, France
Founded
2023
Team Size
150+

Topics

Fundraising(2912)AI/ML(484)StrategicPoolside

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min read•$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min read•$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free